Eight healthcare executives discussed their views on the JPM Healthcare Conference 2024. Topics included the importance of the conference for attracting investors, a sense of optimism in capital markets, the need for workforce intelligence in healthcare systems, partnerships with large pharmaceutical companies, and the importance of AI in drug discovery. Additionally, women’s health, M&A activity in pharma, patient-centricity in geo-political situations, combating obesity, automation in healthcare, and using in-silico approaches in drug development were discussed.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
